Advancing Regenerative Healthcare 
Pushing boundaries together to create meaningful impact. 

Laboratory image of Regenerative Medicines
labimage_Regenerative Medicines
Built on integrated expertise

The production of regenerative medicine therapies requires strict compliance with standards such as GCTP and GMP. Materials and equipment used throughout the manufacturing process — including cell culture containers, culture media, preservation containers, and manufacturing facilities — must meet demanding quality and sterility requirements. 

One of NIPRO’s strengths lies in our ability to develop and supply many of these critical components in-house. Combined with our experience in sterile manufacturing and established quality management systems, this provides a strong foundation for our regenerative medicine activities. 

labimage_Regenerative Medicines
Supporting the future of regenerative therapies

As regenerative medicine continues to evolve, NIPRO remains focused on expanding treatment possibilities and supporting the advancement of innovative therapies. Ongoing efforts include advancing therapies such as STEMIRAC® Injection into additional applications, including chronic spinal cord injury and ALS. 

By continuously strengthening our technologies, collaborative networks, and manufacturing capabilities, we aim to contribute to the future of regenerative healthcare and help bring innovative therapies to more patients worldwide.